Early retention of 237 Pu + 239 Pu in mature beagles. 1978

R D Lloyd, and S S McFarland, and D R Atherton, and F W Bruenger, and G N Taylor, and C W Mays

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D011005 Plutonium A naturally radioactive element of the actinide metals series. It has the atomic symbol Pu, and atomic number 94. Plutonium is used as a nuclear fuel, to produce radioisotopes for research, in radionuclide batteries for pacemakers, and as the agent of fission in nuclear weapons.
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

R D Lloyd, and S S McFarland, and D R Atherton, and F W Bruenger, and G N Taylor, and C W Mays
December 1962, Health physics,
R D Lloyd, and S S McFarland, and D R Atherton, and F W Bruenger, and G N Taylor, and C W Mays
January 1964, HW-SA [reports]. U.S. Atomic Energy Commission,
R D Lloyd, and S S McFarland, and D R Atherton, and F W Bruenger, and G N Taylor, and C W Mays
December 1962, Health physics,
R D Lloyd, and S S McFarland, and D R Atherton, and F W Bruenger, and G N Taylor, and C W Mays
December 1962, Health physics,
R D Lloyd, and S S McFarland, and D R Atherton, and F W Bruenger, and G N Taylor, and C W Mays
October 1974, Health physics,
R D Lloyd, and S S McFarland, and D R Atherton, and F W Bruenger, and G N Taylor, and C W Mays
December 1962, Health physics,
R D Lloyd, and S S McFarland, and D R Atherton, and F W Bruenger, and G N Taylor, and C W Mays
December 1962, Health physics,
R D Lloyd, and S S McFarland, and D R Atherton, and F W Bruenger, and G N Taylor, and C W Mays
June 1975, Health physics,
R D Lloyd, and S S McFarland, and D R Atherton, and F W Bruenger, and G N Taylor, and C W Mays
December 1962, Health physics,
R D Lloyd, and S S McFarland, and D R Atherton, and F W Bruenger, and G N Taylor, and C W Mays
January 1963, HW-SA [reports]. U.S. Atomic Energy Commission,
Copied contents to your clipboard!